Amphastar Pharmaceuticals (AMPH) EV to EBITDA (2014 - 2026)
Amphastar Pharmaceuticals' (AMPH) EV to EBITDA came in at 3.31 for Q2 2026, down 5.1% from 3.49 a year earlier and down 0.9% from the prior quarter.
Powered by 
Analysis
Amphastar Pharmaceuticals (AMPH) EV to EBITDA (2014 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EV to EBITDA at Amphastar Pharmaceuticals was -1.65; for FY2025, it came in at 4.77, down 20.3% from FY2024.
- In prior years, Amphastar Pharmaceuticals' EV to EBITDA was 5.98 in FY2024 (-48.1%), 11.53 in FY2023 (+19.1%), 9.68 in FY2022 (-19.3%) and 12.01 in FY2021 (-71.8%).
- The Q2 2026 figure stands as the lowest quarterly EV to EBITDA in data going back to Q2 2014.
- On a year-over-year basis, EV to EBITDA has declined in each of the last ten quarters, with an average decline of 29.0% over the last eight quarters.
- The strongest year-over-year quarter for EV to EBITDA in the past five years was Q2 2023, with growth of 28.0%; the weakest was Q3 2021, with a decline of 72.2%.
- According to Business Quant data, EV to EBITDA for the three prior quarters was 3.34 (Q1 2026), 4.77 (Q4 2025) and 4.66 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Amphastar Pharmaceuticals | 1.16 Bn | 23.86 Mn | 93.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.31 |
| Mar 31, 2026 | 3.34 |
| Dec 31, 2025 | 4.77 |
| Sep 30, 2025 | 4.66 |
| Jun 30, 2025 | 3.49 |
| Mar 31, 2025 | 4.52 |
| Dec 31, 2024 | 5.80 |
| Sep 30, 2024 | 7.55 |
| Jun 30, 2024 | 5.94 |
| Mar 31, 2024 | 7.07 |
| Dec 31, 2023 | 11.53 |
| Sep 30, 2023 | 9.18 |
| Jun 30, 2023 | 18.15 |
| Mar 31, 2023 | 12.10 |
| Dec 31, 2022 | 9.68 |
| Sep 30, 2022 | 11.09 |
| Jun 30, 2022 | 14.17 |
| Mar 31, 2022 | 16.84 |
| Dec 31, 2021 | 12.01 |
| Sep 30, 2021 | 13.33 |
API Access
Amphastar Pharmaceuticals EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=AMPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "AMPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=AMPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();